Literature DB >> 10882576

Duration of viremia in hepatitis A virus infection.

W A Bower1, O V Nainan, X Han, H S Margolis.   

Abstract

The duration of viremia and time course for development of IgM antibodies were determined prospectively in natural and experimental hepatitis A virus (HAV) infection. Serial serum samples from HAV-infected men (n=13) and experimentally infected chimpanzees (n=5) were examined by nested reverse-transcriptase polymerase chain reaction analysis to detect HAV RNA and by ELISA to detect IgM antibodies to HAV. Among infected humans, HAV RNA was detected an average of 17 days before the alanine aminotransferase peak, and viremia persisted for an average of 79 days after the liver enzyme peak. The average duration of viremia was 95 days (range, 36-391 days). Results were similar in chimpanzees. In addition, HAV RNA was detected in serum of humans and chimpanzees several days before IgM antibodies to HAV were detected. These results indicate that adults with HAV infection are viremic for as long as 30 days before the onset of symptoms and that the duration of viremia may be longer than previously described.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882576     DOI: 10.1086/315701

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  Development and evaluation of a broadly reactive TaqMan assay for rapid detection of hepatitis A virus.

Authors:  N Jothikumar; T L Cromeans; M D Sobsey; B H Robertson
Journal:  Appl Environ Microbiol       Date:  2005-06       Impact factor: 4.792

Review 2.  Diagnosis of hepatitis a virus infection: a molecular approach.

Authors:  Omana V Nainan; Guoliang Xia; Gilberto Vaughan; Harold S Margolis
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Hepatitis A virus in urban sewage from two Mediterranean countries.

Authors:  R M Pintó; D Alegre; A Domínguez; W M El-Senousy; G Sánchez; C Villena; M I Costafreda; L Aragonès; A Bosch
Journal:  Epidemiol Infect       Date:  2006-07-03       Impact factor: 2.451

4.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

5.  Molecular characterization of hepatitis a virus isolates from a transcontinental shellfish-borne outbreak.

Authors:  Glòria Sánchez; Rosa M Pintó; Hermelinda Vanaclocha; Albert Bosch
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Epidemiology and genetic characterization of hepatitis A virus genotype IIA.

Authors:  Delphine Desbois; Elisabeth Couturier; Vincent Mackiewicz; Arielle Graube; Marie-José Letort; Elisabeth Dussaix; Anne-Marie Roque-Afonso
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

7.  Phylogenetic analysis of a transfusion-transmitted hepatitis A outbreak.

Authors:  Andrea Hettmann; Gabriella Juhász; Ágnes Dencs; Bálint Tresó; Erzsébet Rusvai; Éva Barabás; Mária Takács
Journal:  Virus Genes       Date:  2016-09-23       Impact factor: 2.332

8.  Current hepatitis A status in Canada.

Authors:  J Wu; S Zou; A Giulivi
Journal:  Can J Infect Dis       Date:  2001-11

9.  Evaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM.

Authors:  Hyeok-Jin Lee; Hye Sook Jeong; Byung-Ki Cho; Mi-Jeong Ji; Ji-Ha Kim; An-Na Lee; Kyoung-Ryul Lee; Doo-Sung Cheon
Journal:  Virol J       Date:  2010-07-19       Impact factor: 4.099

Review 10.  Bloodborne viral hepatitis infections among drug users: the role of vaccination.

Authors:  Fabio Lugoboni; Gianluca Quaglio; Paolo Civitelli; Paolo Mezzelani
Journal:  Int J Environ Res Public Health       Date:  2009-01-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.